Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

Completed

• Conditions: Patients Transplanted With NiCord/CordIn (Omidubicel)

• Registration Number: NCT02039557
• Lead Sponsor: Gamida Cell ltd

Brief Summary

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-01-13
• Study First Submitted QC: 2014-01-15
• Study First Posted: 2014-01-17
• Study Start: 2014-05-01
• Primary Completion: 2023-06-29
• Study Completion: 2023-06-29
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-22
• Last Update Posted: 2024-10-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
long term sustained chimerism of NiCord®/CordIn™ (omidubicel) transplantation	5 years

Trial Locations

Locations (9)

UCSF Benioff Children's Hospital; 🇺🇸 Oakland, California, United States

Loyola University, Cardinal Bernardin Cancer Center; 🇺🇸 Maywood, Illinois, United States

Duke University Medical Center; 🇺🇸 Durham, North Carolina, United States

Vanderbilt; 🇺🇸 Nashville, Tennessee, United States

University Medical Center Utrecht; 🇳🇱 Utrecht, Netherlands

National University Cancer Institute; 🇸🇬 Singapore, Singapore

Singapore General Hospital; 🇸🇬 Singapore, Singapore

University Hospital Vall D'Hebron; 🇪🇸 Barcelona, Spain

Hospital Universitario La Fe; 🇪🇸 Valencia, Spain